Taken together, these data suggest that verbascoside protects β-cell from dysfunctions associated with ER-stress and acts by modulating the PERK branch of the UPR, a pathway deregulated in diabetes [41]. This evidence concerns the gene EIF2AK3 and diabetes mellitus.